Article Text

Download PDFPDF
Do inhaled corticosteroids decrease the risk of cardiovascular outcomes in patients with chronic obstructive pulmonary disease?

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors This editorial was written by DMM, who is the guarantor for its contents.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests DM is a consultant to Astra-Zeneca, GlaxoSmithKline, Regeneron, Genentech, Up to Date, and the COPD Foundation, and a Medical Expert for the Schlesinger Law Firm.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles